PPI‐Induced Changes in Plasma Metabolite Levels Influence Total Hip Bone Mineral Density in a UK Cohort

Proton pump inhibitors (PPIs) are among the most used drugs in the UK. PPI use has been associated with decreased bone mineral density (BMD) and increased fracture risk, although these results have been inconsistent. We hypothesized that PPI could modulate BMD by altering gut and/or host systemic me...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinyuan, Adebayo, Adewale S., Wang, Dongmeng, Raza, Yasrab, Tomlinson, Max, Dooley, Hannah, Bowyer, Ruth C.E., Small, Kerrin S., Steves, Claire J., Spector, Tim D., Duncan, Emma L., Visconti, Alessia, Falchi, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108201/
https://www.ncbi.nlm.nih.gov/pubmed/36458982
http://dx.doi.org/10.1002/jbmr.4754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108201/
https://www.ncbi.nlm.nih.gov/pubmed/36458982
http://dx.doi.org/10.1002/jbmr.4754

Ejemplares similares